Cancer Res 61:1320–1326PubMed 6. Sadlonova A, Mukherjee S, Bowe DB et al (2007) Human breast fibroblasts inhibit
growth of the MCF10AT xenograft model of proliferative breast disease. Am J Pathol 170:1064–1076CrossRefPubMed 7. Tan TT, Coussens LM (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19:209–216CrossRefPubMed 8. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550CrossRefPubMed 9. Hawsawi NM, Ghebeh H, Hendrayani SF et al (2008) Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68:2717–2725CrossRefPubMed 10. Koyama H, Kobayashi N, Harada M et al (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 172:179–193CrossRefPubMed https://www.selleckchem.com/products/AZD2281(Olaparib).html 11. Sasser AK, Mundy BL, Smith KM et al (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254:255–264CrossRefPubMed
12. Kuperwasser C, Chavarria T, Wu M et al (2004) From the cover: reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 101:4966–4971CrossRefPubMed 13. Blanquicett C, Johnson MR, Heslin M, Diasio RB (2002) Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal Biochem 303:209–214CrossRefPubMed 14. Frost AR, Sparks D, Grizzle WE (2000) Methods Topoisomerase inhibitor of antigen recovery
vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl Immunohistochem Mol Morphol 8:236–243CrossRefPubMed 15. Talley LI, Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR (2002) Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 98:118–127CrossRefPubMed 16. Chhieng DC, Tabbara SO, Marley EF, Talley LI, Frost AR Abiraterone supplier (2003) Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J 9:200–207CrossRefPubMed 17. Grizzle WE, Myers RB, Manne U, Stockard CR, Harkins LE, Srivastava S (1998) Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia. In: Hanausek M, Walaszek Z (eds) John Walker’s methods in molecular medicine—tumor marker protocols. Humana, Totowa, NJ, pp 161–179 18. Pupa SM, Argraves WS, Forti S et al (2004) Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 23:2153–2160CrossRefPubMed 19. Trivedi P, Edwards JW, Wang J et al (2005) HDBStat!: a platform-independent software suite for statistical analysis of high dimensional biology data. BMC Bioinformatics 6:86CrossRefPubMed 20.